/PRNewswire/ Anuncia Medical, Inc., announced that the U.S. Food and Drug Administration (FDA) cleared the ReFlow® System Mini for the treatment of patients.
Investegate announcements from Argá Medtech, Argá Medtech Shows Promise for New Cardiac Ablation Technology at 2022 Heart Rhythm Society Annual Meeting
Argá Medtech's next-generation non-thermal cardiac ablation system shows promise in improving precision, speed and flexibility in treating atrial fibrillationPreliminary feasibility study results demonstrate